Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-03-01FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for XANAX XR (alprazolam) filed by Viatris Specialty LLC.
-
FDA approval · 2021-02-16FDA Approved: PAROXETINE — Original Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' generic paroxetine (PAROXETINE) via an Original Application (ANDA213485). It covers indication…
-
FDA approval · 2021-02-06FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2021-02-05FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alprazolam submitted by Mylan Pharmaceuticals, contributing to the existing approval for thi…
-
FDA approval · 2021-02-05FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for clonazepam from Teva Pharmaceuticals USA, Inc., to modify labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-05FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for XANAX XR (alprazolam) from Viatris Specialty LLC. The action involves changes to the product…
-
FDA label_change · 2021-02-05FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for KLONOPIN (clonazepam) from H2-Pharma, LLC, resulting in changes to the product labeling.
-
FDA approval · 2021-02-05FDA Approved: CLONAZEPAM — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for clonazepam from Alembic Pharmaceuticals Inc., bringing a generic clonazepam product to market.
-
FDA approval · 2021-02-05FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for alprazolam by Actavis Pharma, Inc., enabling a generic alprazolam product.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks [Phase 4]
Phase 4 trial assessing safety of extended release alprazolam in adolescents with panic disorder; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder [Phase 4]
Phase 4 trial evaluating extended-release alprazolam in adolescents with panic disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder [Phase 4]
Phase 4 trial updating long-term use of alprazolam extended-release in adolescents with panic disorder; study terminated.
-
FDA approval · 2021-01-22FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for clonazepam from Par Health USA, LLC under an ANDA, signaling approval of a supplemental fili…
-
FDA approval · 2021-01-21FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine submitted by Alembic Pharmaceuticals Limited.
-
FDA approval · 2020-12-23FDA Approved: FLUOXETINE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for Fluoxetine from Cadila Pharmaceuticals Limited, enabling the marketing of this generic fluoxetin…
-
FDA approval · 2020-11-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for venlafaxine hydrochloride (generic) under ANDA076565, enabling it…
-
FDA approval · 2020-10-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the generic venlafaxine hydrochloride (venlafaxine) under Original Application for the treatment of major depressive disorder, …
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: The Modular Protocol for Mental Health (MPMH) [Phase 1, Phase 2]
Phase 1 and Phase 2 study of the Modular Protocol for Mental Health (MPMH) completed; investigates treatment approaches for multiple mental …
-
FDA approval · 2020-08-07FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for clomipramine hydrochloride (generic) from Rising Pharma Holdings, Inc., enabling a generic product…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Online Treatments for Mood and Anxiety Disorders in Primary Care [Phase 2, Phase 3]
Phase 2/3 clinical trial update evaluating online treatments for mood and anxiety disorders in primary care; completed.
-
FDA approval · 2020-07-21FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Paroxetine hydrochloride from Apotex Corp., enabling continued marketing of a generic product.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD [Phase 4]
Phase 4 clinical trial evaluating quetiapine XR with divalproex ER for anxiety symptoms in bipolar disorder patients with panic disorder and…
-
FDA approval · 2020-06-10FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic fluoxetine through an Original Application (ANDA).
-
FDA approval · 2020-04-28FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.